Crossmark

Identification of novel triazolopyrimidines as potent α-glucosidase inhibitor through design, synthesis, biological evaluations, and computational analysis

Crossref DOI link: https://doi.org/10.1038/s41598-025-23387-z

Published Online: 2025-11-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peytam, Fariba

Norouzbahari, Maryam

Gulcan, Hayrettin Ozan

Hosseini, Faezeh Sadat

Moghadam, Mahdis Sadeghi

Mojtabavi, Somayeh

Faramarzi, Mohammad Ali

Ghasemi, Fahimeh

Torabi, Mohammadreza

Sadat-Ebrahimi, Seyed Esmaeil

Tehrani, Maliheh Barazandeh

Firoozpour, Loghman

Foroumadi, Alireza
Funding

Funding for this research was provided by:

Tehran University of Medical Sciences and Health Services (1400-3-104-55709)

Tehran University of Medical Sciences and Health Services (1404-4-153-92397)
License Information

Text and Data Mining valid from 2025-11-12

Version of Record valid from 2025-11-12
More Information

Article History

Received: 14 August 2025

Accepted: 6 October 2025

First Online: 12 November 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below